Suppl. Figure 1 from Oxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy–Tolerant Persister Cells in ER+ Breast Cancer
Steven Tau, Mary D. Chamberlin, Huijuan Yang, Jonathan D. Marotti et autres
0 citations
James V. Alvarez
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
188Publications signalées
2923Citations signalées
1Affiliations récentes
Institutions déclarées
Domaines associés
Cancer, Hypoxia, and MetabolismLung Cancer Treatments and MutationsEstrogen and related hormone effectsRetinoids in leukemia and cellular processesEpigenetics and DNA Methylation
Publications récentes
Suppl. Figure 2 from Oxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy–Tolerant Persister Cells in ER+ Breast Cancer
Steven Tau, Mary D. Chamberlin, Huijuan Yang, Jonathan D. Marotti et autres
0 citations
Supplementary Table 9 from Oxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy–Tolerant Persister Cells in ER+ Breast Cancer
Steven Tau, Mary D. Chamberlin, Huijuan Yang, Jonathan D. Marotti et autres
0 citations
Supplementary Table 11 from Oxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy–Tolerant Persister Cells in ER+ Breast Cancer
Steven Tau, Mary D. Chamberlin, Huijuan Yang, Jonathan D. Marotti et autres
0 citations
Supplementary Table 6 from Oxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy–Tolerant Persister Cells in ER+ Breast Cancer
Steven Tau, Mary D. Chamberlin, Huijuan Yang, Jonathan D. Marotti et autres
0 citations
Suppl. Figure 6 from Oxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy–Tolerant Persister Cells in ER+ Breast Cancer
Steven Tau, Mary D. Chamberlin, Huijuan Yang, Jonathan D. Marotti et autres
0 citations
Supplementary Table 8 from Oxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy–Tolerant Persister Cells in ER+ Breast Cancer
Steven Tau, Mary D. Chamberlin, Huijuan Yang, Jonathan D. Marotti et autres
0 citations
Supplementary Table 12 from Oxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy–Tolerant Persister Cells in ER+ Breast Cancer
Steven Tau, Mary D. Chamberlin, Huijuan Yang, Jonathan D. Marotti et autres
0 citations
Suppl. Figure 4 from Oxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy–Tolerant Persister Cells in ER+ Breast Cancer
Steven Tau, Mary D. Chamberlin, Huijuan Yang, Jonathan D. Marotti et autres
0 citations
Supplementary Table 7 from Oxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy–Tolerant Persister Cells in ER+ Breast Cancer
Steven Tau, Mary D. Chamberlin, Huijuan Yang, Jonathan D. Marotti et autres
0 citations
Supplementary Table 3 from Oxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy–Tolerant Persister Cells in ER+ Breast Cancer
Steven Tau, Mary D. Chamberlin, Huijuan Yang, Jonathan D. Marotti et autres
0 citations
Supplementary Table 1 from Oxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy–Tolerant Persister Cells in ER+ Breast Cancer
Steven Tau, Mary D. Chamberlin, Huijuan Yang, Jonathan D. Marotti et autres
0 citations
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.